Shareholding disclosure

Aviva Plc

Declared position

6.36%

Threshold

Crossed upwards

Timeline

Published

20.03.2020

Transaction

16.03.2020

Voting rights breakdown

Voting rights acquired6.36%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAK3J000B9

Beneficial owner

Aviva Plc

Declared address

Aviva Plc, LONDON EC3P 3DQ

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Aviva Plc

Newron Pharmaceuticals S.p.A.20.03.2020TAK3J000B9

Disclosure summary

Aviva Plc disclosed a holding in Newron Pharmaceuticals S.p.A. on the acquisition side, published by SIX Exchange Regulation on 20.03.2020, at 6.36% of voting rights. Notice category: Single shareholder.

Disclosed position

6.36%

Voting rights acquired

Voting rights acquired6.36%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Aviva Plc disclosed a holding in Newron Pharmaceuticals S.p.A., published on 20.03.2020.

Publication date20.03.2020

Transaction date16.03.2020

Issuing companyNewron Pharmaceuticals S.p.A.

Beneficial ownerAviva Plc

Declared addressAviva Plc, LONDON EC3P 3DQ

CategorySingle shareholder

Voting rights acquired6.36%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAK3J000B9

Source: SIX Exchange Regulation · Publication date: 20.03.2020

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open